Abstract
In order to discover new cancer chemopreventive agents from natural or synthetic products, a structurally diverse class of chemopreventive agents was evaluated usingin vitro biomarker of inhibition of 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced ornithine decarboxylase (ODC) activity in cultured mouse epidermal 308 (ME 308) cells. As a result, apigenin, benzylisothiocyanate, curcumin, diallyl disulfide,N-(4-hydroxyphenyl)retinamide (4-HPR), menadione, miconazole, nordihydroguaiaretic acid (NDGA) and phenethyl isothiocyanate showed potent inhibitory effects in this process. A chemically diverse group of compounds was included in the evaluation, such as flavonoids, retinoids, isothiocyanates, sulfur-containing compounds and phenolic antioxidant compounds. These data are suggestive to understand the cancer chemopreventive potential mediated by these substances.
Similar content being viewed by others
References cited
Auvinen, M., Paasinen, A., Anderson, I. C. and Hölttä, E., Ornithine decarboxylase activity is critical for cell transformation.Nature, 360, 355–358 (1992).
Brady, J. F., Li, D. C., Ishizaki, H. and Yang, C. S., Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities.Cancer Res., 48, 5937–5940 (1988).
Gilmour, S. K., Robertson, F. M., Megosh, L., OConnell, S. M., Mitchell, J. and OBrien, T. G., Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate.Carcinogenesis, 13, 51–56 (1992).
Hayes, M.A., Rushmore, T.H. and Goldberg, M.T., Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydrazine by diallyl sulfide, a component of garlic oil.Carcinogenesis, 8, 1155–1157 (1987).
Huang, M.-T., Ho, C. T., Wang, Z. Y., Farraro, T., Finnegan-Olive, T., Lou, Y.R., Mitchell, J.M., Laskin, J.D., Yang, C.S. and Conney, A.H., Inhibitory effects of topical application of green tea polyphenol fraction on tumor initiation and promotion in mouse skin.Carcinogenesis, 13, 947–954 (1992).
Huang, M.-T., Ma, W., Lu, Y.-P. Chang, R. L., Fisher, C., Manchand, P. S., Newmark, H. L. and Conney, A. H., Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion.Carcinogenesis, 16, 2493–2497 (1995).
Huang, M.-T., Smart, R. C., Wong, C.-Q. and Conney, A. H., Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate.Cancer Res., 48, 5941–5946 (1988).
Kahana, C. and Nathans, D., Isolation of cloned cDNA encoding mammalian ornithine decarboxylase.Proc. Natl. Acad. Sci., USA, 81, 3645–3649 (1984).
Katz, A. and Kahana, C., Transcriptional activation of mammalian ornithine decarboxylase during stimulated growth.Mol. Cell Biol., 7, 2641–2643 (1987).
Kelloff, G. J., Chemopreventive drug development: Perspectives and progress.Cancer Epidemiol. Biomarkers & Prev., 3, 85–98 (1994).
Lee, S. K., Song, L., Mata-Greenwood, E., Kelloff, G. J., Steele, V. E. and Pezzuto, J. M., Modulation of in vitro biomarkers of the carcinogenic process by chemopreventive agents.Anticancer Res., 19, 35–44 (1999).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall R. J., Protein measurement with the folin phenol reagent.J. Biol. Chem., 193, 265–275 (1951).
McCann, P. and Pegg, A. E., Ornithine decarboxylase as an enzyme target for therapy.Pharmac Ther., 54, 195–215 (1992).
McCormick, D. L. and Spicer, A. M., Nordihydroguaiaretic acid suppression of rat mammary carcinogenesis induced byN-methyl-N-nitrosourea.Cancer Lett., 37, 139–146 (1987).
Mehta, R. G. and Moon, R. C., Characterization of effective chemopreventive agents in mammary glandin vitro using an initiation-promotion protocol.Anticancer Res., 11, 593–596 (1991).
Metcalf, B. W., Bey, P., Danzin, C., Jung, M. J., Casara, P. and Vevert, J. P., Catalystic irreversible inhibition of mammalian ornithine decarboxylase by substrate and product analogues.J. Am. Chem. Soc., 100, 2551–2553 (1978).
Nagabhushan, M. and Bhide, S. V., Curcumin as an inhibitor of cancerJ. Am. Coll. Nutr., 11, 192–198 (1992).
Nakadate, T., Yamamoto, S., Aizu, E. and Kato, R., Effects of flavonoids and antioxidants on 12-O-tetradecanoylphorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these components.Gann, 75, 214–222 (1984).
Nakadate, T., Yamamoto, S., Iseki, H., Sonoda, S., Takemaru, S., Ura, A., Hosoda, T. and Kato, R., Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid a lipoxygenase inhibitor, andp-bromophenacryl bromide, a phospholipase A2 inhibitor.Gann, 73, 841–843 (1982).
OBrien, T. G., Megosh, L. C., Gilliard G. and Soler, A. P., Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin.Cancer Res., 57, 2630–2637 (1997).
Pegg, A. E., Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy.Cancer Res., 48, 759–774 (1988).
Pegg, A. E. and McCann, P. P., Polyamine metabolism and function: a review.Am. J. Physiol., 243, 212–221 (1982).
Peña, A., Reddy, C. D., Wu, S., Hickok, N. J., Reddy, E. P., Yumet, G., Soprano, D. R. and Soprano, K.J., Regulation of human ornithine decarboxylase express-sion by the c-Myc-Max protein complex.J. Biol. Chem., 268, 27277–27285 (1993).
Pohjanpelto, P., Holtta, E. and Janne, O. A., Mutant strain of Chinese hamster ovary cells with no detectable ornithine decarboxylase activity.Mol. Cell. Biol., 5,
Shantz, L. M., Hu, R.-H. and Pegg, A. E., Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translocation initiation factor elF-4E.Cancer Res., 56, 3265–3269 (1996).
Sharma, O. P., Antioxidant activity of curcumin and related compounds.Biochem. Pharmacol., 25, 1811–1812 (1976).
Sharma, S., Stutzman, J. D., Kelloff, G. J. and Steele, V. E., Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.Cancer Res., 54, 5848–5855 (1994).
Smith, W. A. and Gupta, R., Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents.Carcinogenesis, 17, 1285–1290 (1996).
Srimal, R. C. and Dhawan, B. N., Pharmacology of diferuloylmethane (curcumin), a non-steroidal antiinflammatory agent.J. Pharm. Pharmacol., 25, 447–452 (1973).
Strickalnd, J. E., Greenhalgh, D. A., Koceva-Chyla, A., Hennings, H., Restrepo, C., Balaschak, M. and Yuspa, S. H., Development of murine epidermal cell lines which contain an activatedrasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts.Cancer Res., 48, 165–169 (1988).
Szarka, C. E., Grana, G. and Engstrom, P., Chemoprevention of cancer.Curr. Probl. Cancer, 18, 1–78 (1994).
Thompson, H. L. and Roman, A. M., Effects of DL-2-di-fluoromethyl-ornithine and endocrine manipulation on their induction of mammary carcinogenesis by MNU.Carcinogenesis, 7, 2003–2006 (1986).
Tobias, K. E. and Kahana, C., Intersubunit location of the active site of mammalian ornithine decarboxylase as determine by hybridization of site-directed mutants.Biochemistry, 32, 5842–5847 (1993).
van Daalen Wetters, T., Brabant, M. and Collino, P., Regulation of ornithine decarboxylase activity by cell growth, serum and tetradecanoylphorbol acetate is governed primarily by sequences within the coding region of the gene.Nucleic Acids Res., 17, 9843–9860 (1989).
Verma, A. K. and Boutwell, R. K., Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis.Cancer Res., 37, 2196–2201 (1977).
Verma, A. K., Shapas, B. G., Rice, H. M. and Boutwell, R. K., Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion.Cancer Res., 39, 419–425 (1979).
Verma, A. K., Inhibition of tumor promoter 12-O-tetra decanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.Cancer Res., 48, 2168–2173 (1988).
Wargovich, M. J., Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer.Carcinogenesis, 8, 487–489 (1987).
Wargovich, M. J. and Goldberg, M. T., Diallyl sulfide, a naturally occurring thioehter that inhibits carcinogen-induced nuclear damage to colon epithelial cells in vivo.Mutat. Res., 143, 127–129 (1985).
Wei, H., Tye, L., Brensnick, E. and Birt, D. F., Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice.Cancer Res., 50, 499–502 (1990).
Williams-Ashman, H. G. and Canellakis, Z. N., Polyamines in mammalian biology and medicine.Perspect. Biol. Med., 22, 421–453 (1979).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, S.K., Pezzuto, J.M. Evaluation of the potential of cancer chemopreventive activity mediated by inhibition of 12-O-tetradecanoyl phorbol 13-acetate-induced ornithine decarboxylase activity. Arch Pharm Res 22, 559–564 (1999). https://doi.org/10.1007/BF02975326
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02975326